Cagrilintide 5mg from Kensington Labs achieved 99.778% purity in independent HPLC analysis conducted by Janoshik Labs on September 12, 2025. The tested quantity of 5.23mg exceeds the labeled 5mg specification, indicating accurate labeling and manufacturing quality.
Cagrilintide is a GLP-1 receptor agonist researched for its role in metabolic regulation and weight management. A purity level of 99.778% confirms minimal contamination and high-grade synthesis quality.
The full certificate of analysis is available for verification at www.janoshik.com/verify/ using the unique key KYKW44SY6Z3U.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.